Genesis Labs is pleased to offer testing for SARS-CoV-2 (COVID – 19) as well as for the IgG and IgM antibodies to assess previous COVID-19 infection. We began offering to test patient COVID-19 samples from local providers and Urgent Care Centers on March 18, 2020. Since then, we have tested thousands of patient samples in Continental, USA. As of May 15, 2020, we are now offering antibody testing for clinical use.

We at Genesis Labs understand the importance of obtaining these results in a timely manner and pride ourselves on our quick turnaround-time (24 – 36 hours in the majority of cases) and excellent customer service. As always, we are available 24 hours a day, seven days a week, to provide clinical support to our clinicians, ultimately ensuring that you receive incomparable customer service, especially in a time like this.

Testing for the SARS-CoV-2 Virus (also known as COVID-19 testing) is available to licensed health care providers who desire to have their patients tested for the virus and/or for related antibodies, as well as respiratory diseases that need to be ruled out as non-COVID-19 infectious agents suspected of causing illness in patients.

Specifically, as long as there is a declared state of emergency and that state of emergency is not modified, patients with insurance will be billed either: (a) if Genesis is in-network with your insurance carrier, at the network negotiated price, or (b) if out-of-network Genesis will bill at the cash price rates found below. If you have no insurance, you will not be billed so long as the declared federal state of emergency exists and the Federal Government is paying for COVID-19 testing of patients who do not have insurance.

Please click here to see important message regarding patients who are uninsured.

In any event, so long as required by law, no patient will be balance billed for any co-payment or deductible during the declared state of emergency. Please click this link to see important message regarding patients who are uninsured.

It should be noted that for the purposes of compliance with the CARES Act and the New Jersey “Out-of-Network Consumer Protection, Transparency, Cost Containment and Accountability Act of 2018”, Genesis is required to publish the cash price/charges for the SARS-CoV-2 Virus (a/k/a COVID-19) test, which is $513.00 for CPT Code 87635/U0003/U0004 (after 4-14-20). The cash price/charges for IgG antibodies is $179.00 for CPT Code 86769, and the cash price/charges for IgM antibodies is $119.00 for CPT Code 86769/CS. These cash prices/charges do not include the cash prices/charges for clinical laboratory tests related to other pathogens (such as bacteria and other viruses), which such tests may also be ordered by a health care provider even if they are COVID-19 related to in to rule out other contributory pathogens. Please click this link for the cash price/charges of other clinical laboratory tests for respiratory pathogens offered by Genesis.